When and where does inflammation begin in rheumatoid arthritis?

被引:146
作者
Demoruelle, M. Kristen [1 ]
Deane, Kevin D. [1 ]
Holers, V. Michael [1 ]
机构
[1] Univ Colorado, Sch Med, Div Rheumatol, Aurora, CO 80045 USA
基金
美国国家卫生研究院;
关键词
autoimmunity; cause; inflammation; preclinical; rheumatoid arthritis; CYCLIC CITRULLINATED PEPTIDE; UNAFFECTED 1ST-DEGREE RELATIVES; PROTEIN ANTIBODIES; PORPHYROMONAS-GINGIVALIS; PERIODONTITIS PATIENTS; POSITIVE ARTHRALGIA; INCREASED RISK; DISEASE; ONSET; IGG;
D O I
10.1097/BOR.0000000000000017
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Purpose of reviewThe cause of rheumatoid arthritis (RA), as well as the timing and anatomic site at which RA-related autoimmunity is initiated, is currently unknown. An improved understanding of the initial steps in the development of RA would provide insights into disease pathogenesis that could ultimately lead to more effective treatments and/or novel preventive strategies in RA.Recent findingsSystemic inflammation and autoimmunity in RA begin long before the onset of detectable joint inflammation. Emerging data suggest that RA-related autoimmunity may be initiated at a mucosal site years before the onset of joint symptoms. The candidate sites of origin include the oral, lung and gastrointestinal mucosa, as data consistent with this hypothesis have been generated for each location. Individual patients may undergo initiation events at unique sites, but still converge on similar joint findings as the disease process evolves.SummaryInvestigations are needed to determine when and where RA begins, including comprehensive prospective studies of individuals in the preclinical period of RA that can provide insight into the relationship between mucosal inflammation, RA-related autoantibody generation and subsequent joint inflammation in RA.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 77 条
[1]
Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis [J].
Abdollahi-Roodsaz, Shahla ;
Joosten, Leo A. B. ;
Koenders, Marije I. ;
Devesa, Isabel ;
Roelofs, Mieke F. ;
Radstake, Timothy R. D. J. ;
Heuvelmans-Jacobs, Marleen ;
Akira, Shizuo ;
Nicklin, Martin J. H. ;
Ribeiro-Dias, Fatima ;
Van den Berg, Wim B. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01) :205-216
[2]
WHEN DOES RHEUMATOID DISEASE START [J].
AHO, K ;
PALOSUO, T ;
RAUNIO, V ;
PUSKA, P ;
AROMAA, A ;
SALONEN, JT .
ARTHRITIS AND RHEUMATISM, 1985, 28 (05) :485-489
[3]
Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden [J].
Arlestig, Lisbeth ;
Mullazehi, Mohammed ;
Kokkonen, Heidi ;
Rocklov, Joacim ;
Ronnelid, Johan ;
Dahlqvist, Solbritt Rantapaa .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) :825-829
[4]
Anticitrullinated Protein Antibodies and Rheumatoid Factor Fluctuate in Early Inflammatory Arthritis and Do Not Predict Clinical Outcomes [J].
Barra, Lillian ;
Bykerk, Vivian ;
Pope, Janet E. ;
Haraoui, Boulos P. ;
Hitchon, Carol A. ;
Thome, J. Carter ;
Keystone, Edward C. ;
Boire, Gilles .
JOURNAL OF RHEUMATOLOGY, 2013, 40 (08) :1259-1267
[5]
Anti-Citrullinated Protein Antibodies in Unaffected First-Degree Relatives of Rheumatoid Arthritis Patients [J].
Barra, Lillian ;
Scinocca, Mathias ;
Saunders, Sheri ;
Bhayana, Rajesh ;
Rohekar, Sherry ;
Racape, Maud ;
Coles, Robert ;
Cairns, Ewa ;
Bell, David A. .
ARTHRITIS AND RHEUMATISM, 2013, 65 (06) :1439-1447
[6]
Musculoskeletal manifestations in cystic fibrosis [J].
Botton, E ;
Saraux, A ;
Laselve, H ;
Jousse, S ;
Le Goff, P .
JOINT BONE SPINE, 2003, 70 (05) :327-335
[7]
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis [J].
Brink, Mikael ;
Hansson, Monika ;
Mathsson, Linda ;
Jakobsson, Per-Johan ;
Holmdahl, Rikard ;
Hallmans, Goran ;
Stenlund, Hans ;
Ronnelid, Johan ;
Klareskog, Lars ;
Rantapaa-Dahlqvist, Solbritt .
ARTHRITIS AND RHEUMATISM, 2013, 65 (04) :899-910
[8]
Bykerk VP, 2013, CLIN EXP RHEUMATOL, V31, P621
[9]
Reactive Arthritis: Clinical Aspects and Medical Management [J].
Carter, John D. ;
Hudson, Alan P. .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2009, 35 (01) :21-+
[10]
Comparison of Threshold Cutpoints and Continuous Measures of Anti-Cyclic Citrullinated Peptide Antibodies in Predicting Future Rheumatoid Arthritis [J].
Chibnik, Lori B. ;
Mandl, Lisa A. ;
Costenbader, Karen H. ;
Schur, Peter H. ;
Karlson, Elizabeth W. .
JOURNAL OF RHEUMATOLOGY, 2009, 36 (04) :706-711